Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Merck & Co. describes endothelin antagonists

Sep. 13, 1996

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Sep. 13, 1996

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

New cholinergic channel activators described by Abbott

Sep. 13, 1996

Inhibitors of C1r for Alzheimer's disease

Sep. 13, 1996

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Sep. 13, 1996

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...